Developmental Disabilities Modification of the Children’s Global Assessment Scale

Wagner, Ann E.; Lecavalier, Luc; Arnold, L. Eugene; Aman, Michael G.; Scahill, Lawrence; Stigler, Kimberly A.; Johnson, Cynthia R.; McDougle, Christopher J.; Vitiello, Benedetto

doi:10.1016/j.biopsych.2007.01.001

Cited by 64 publications

(44 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Because of the possible recall bias, we mainly reported current diagnoses. Recently, a modification of K-SADS-PL (Autism Comorbidity Interview-Present and Lifetime Version; ACI-PL; Leyfer et al 2006) for children and adolescents with autism and a CGAS modification (Developmental Disability-Child Global Assessment Scale; DD-CGAS; Wagner et al 2007) for children with PDDs have been developed. However, this study was drawn up and performed before these modified instruments were available.…”

Section: Discussionmentioning

confidence: 99%

Comorbid Psychiatric Disorders Associated with Asperger Syndrome/High-functioning Autism: A Community- and Clinic-based Study

Mattila

Hurtig

Haapsamo

et al. 2010

J Autism Dev Disord

352

205

View full text Add to dashboard Cite

The present study identifies the prevalence and types of comorbid psychiatric disorders associated with Asperger syndrome (AS)/high-functioning autism (HFA) in a combined community- and clinic-based sample of fifty 9- to 16-year-old subjects using the Schedule for Affective Disorders and Schizophrenia for School-Age Children, Present and Lifetime Version. The level of functioning was estimated using the Children's Global Assessment Scale. The results support common (prevalence 74%) and often multiple comorbid psychiatric disorders in AS/HFA; behavioral disorders were shown in 44%, anxiety disorders in 42% and tic disorders in 26%. Oppositional defiant disorder, major depressive disorder and anxiety disorders as comorbid conditions indicated significantly lower levels of functioning. To target interventions, routine evaluation of psychiatric comorbidity in subjects with AS/HFA is emphasized.

show abstract

Section: Discussionmentioning

confidence: 99%

Comorbid Psychiatric Disorders Associated with Asperger Syndrome/High-functioning Autism: A Community- and Clinic-based Study

Mattila

Hurtig

Haapsamo

et al. 2010

J Autism Dev Disord

352

205

View full text Add to dashboard Cite

show abstract

“…In this trial, the DD-CGAS was completed by IEs blind to treatment condition. As described by Wagner and colleagues (2007), IEs were trained with a set of case vignettes and were required to achieve reliability (i.e., scoring within 10 points of gold standard ratings).…”

Section: Methodsmentioning

confidence: 99%

“… Effect size (between-group) calculation: change in MASSI (endpoint – baseline) – change in WL (endpoint-baseline)/pooled SD for full sample at baseline Effect size (within-group) calculation: change score/SD for group at baseline, corrected for correlation between pre- and post-scores for full sample (Morris & DeShon, 2002) SRS: Social Responsiveness Scale (Constantino & Gruber, 2005); PARS: Pediatric Anxiety Rating Scale (Anxiety Study Group, RUPP, 2002); CASI-Anx: Child and Adolescent Symptom Inventory-4 ASD Anxiety Scale (CASI-Anx; Sukhodolsky et al, 2008); DD-CGAS: Developmental Disabled Children's Global Assessment Scale (DD-CGAS; Wagner et al, 2007). BL: baseline; EP: endpoint…”

Section: Figurementioning

confidence: 99%

“… SRS: Social Responsiveness Scale (Constantino & Gruber, 2005); PARS: Pediatric Anxiety Rating Scale (Anxiety Study Group, RUPP, 2002); CASI-Anx: Child and Adolescent Symptom Inventory-4 ASD Anxiety Scale (CASI-Anx; Sukhodolsky et al, 2008); DD-CGAS: Developmental Disabled Children's Global Assessment Scale (DD-CGAS; Wagner et al, 2007). BL: baseline; EP: endpoint…”

Section: Figurementioning

confidence: 99%

See 1 more Smart Citation

Randomized Controlled Trial: Multimodal Anxiety and Social Skill Intervention for Adolescents with Autism Spectrum Disorder

White

Ollendick

Albano

et al. 2012

J Autism Dev Disord

Self Cite

258

261

View full text Add to dashboard Cite

Anxiety is common among adolescents with autism spectrum disorders (ASD) and may amplify the core social disability, thus necessitating combined treatment approaches. This pilot, randomized controlled trial (RCT) evaluated the feasibility and preliminary outcomes of the Multimodal Anxiety and Social Skills Intervention (MASSI) program in a sample of 30 adolescents with ASD and anxiety symptoms of moderate or greater severity. The treatment was acceptable to families, subject adherence was high, and therapist fidelity was high. A 16% improvement in ASD social impairment (within-group effect size = 1.18) was observed on a parent-reported scale. Although anxiety symptoms declined by 26%, the change was not statistically significant. These findings suggest MASSI is a feasible treatment program and further evaluation is warranted.

show abstract

“…- Level of functioning: using the Developmental Disabilities Modification of the Children's Global Assessment Scale (DD-CGAS [30]; German translation, Bölte [31]) at T0 and T2 (therapists).…”

Section: Methodsmentioning

confidence: 99%

Become Related: FIAS, an Intensive Early Intervention for Young Children with Autism Spectrum Disorders

Herbrecht¹,

Kievit²,

Spiegel³

et al. 2015

Psychopathology

View full text Add to dashboard Cite

Background: In autism spectrum disorders (ASDs), impairments in fundamental social abilities and a lack of interest in social stimuli become apparent early in life. These impairments are thought to negatively affect further brain and behavioural development. Early intensive interventions can help to attenuate social-development and other risk factors and, thus, to ameliorate the deficits associated with ASDs. We present FIAS, an intensive early intervention approach for young children with ASD, which aims at developing children's social motivation. During 18 days, therapists work continuously for 6 h a day with the affected child, involving the whole family in a day care setting. Follow-up care at home over 1 year as well as fresh-up interventions and inclusion in kindergarten or a play group should stabilise the effects and help to respond to further challenges. Material and Methods: Here, we present observations from the first 12 patients (25-48 months of age) treated according to the FIAS approach. We evaluated changes in core autistic symptoms and level of functioning after the 18 days of intensive intervention. Beyond standardised assessment, two innovative video-based instruments (Autism Behaviour Coding System and Evaluationsfragebogen) have been developed to assess autistic symptoms and interaction parameters during intervention. Results: Improvements were noted in most core autistic symptom domains, with the highest effect sizes in domains like eye contact, communication, repetitive behaviour, imitation, motivation and reciprocity. In addition, the level of functioning significantly improved. Conclusions: The first evaluation of the FIAS approach shows promising results, as the FIAS intervention appears to improve core autistic symptom domains as well as the level of everyday functioning. Limitations of this study are the small sample size and the lack of a control group. A more comprehensive and longitudinal evaluation is in progress; this will focus on the stability of the observed effects and will attempt to identify potential predictors of treatment response.

show abstract

Developmental Disabilities Modification of the Children’s Global Assessment Scale

Cited by 64 publications

References 25 publications

Comorbid Psychiatric Disorders Associated with Asperger Syndrome/High-functioning Autism: A Community- and Clinic-based Study

Comorbid Psychiatric Disorders Associated with Asperger Syndrome/High-functioning Autism: A Community- and Clinic-based Study

Randomized Controlled Trial: Multimodal Anxiety and Social Skill Intervention for Adolescents with Autism Spectrum Disorder

Become Related: FIAS, an Intensive Early Intervention for Young Children with Autism Spectrum Disorders

Contact Info

Product

Resources

About